Abiopharma

🔍 Netzly Kyle (Executive)

Company: Groupon, Inc. (GRPN)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 9,197 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 9,197.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Acquired 6,131 shares of Performance Share Units (Derivative)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 6,131.00 | transaction_form_type: 4 | Footnotes: F3, F4, F4

Footnotes:

• F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Groupon, Inc. (the "Issuer") Common Stock.
• F2: The RSUs will vest in three equal tranches (one third on each of May 1, 2027, May 1, 2028, and May 1, 2029), subject to continued service and a year-end performance review modifier of 0% to 300% per tranche.
• F3: Each performance share unit ("PSU") represents a contingent right to receive one share of Issuer Common Stock.
• F4: The number of shares of Common Stock that will be acquired upon the vesting of the PSUs is contingent upon the Company's relative TSR vs. Russell 2000 Index over a three-year performance period (May 1, 2026 to May 1, 2029). The PSUs will cliff vest on May 1, 2029, ranging from 0% (at or below 50th percentile) to 300% (at or above 90th percentile). In the event of negative TSR, payout is capped at 100%.
• REMARKS: Exhibit 24 - Power of Attorney